Thndr Claps » EGY Claps » Health & Pharma 👩⚕️ » PIF shopping continues🛒
The ClapThe Saudi Public Investment Fund (PIF) reportedly acquired a 4.7% stake in Egyptian International Pharmaceuticals “EIPICO” (PHAR).
DeetsThe stake sold reportedly belonged to Dubai-based asset manager “Saray Capital”.
So whatSources claim that this is the first phase of the PIF investing in the pharmaceutical giant as it looks to increase its stake down the line.
Now whatThe PIF is also exploring investment opportunities in the education & health sectors in Egypt, after having acquired several stakes in public companies.
© Thndr. All rights reserved
Disclaimer: Thndr does not provide investment advice, individual investors are responsible for their own decisions or can seek independent advice. The value of investments can go up and down. Thndr is a trading name of Thndr Securities Brokerage which is authorised and regulated by the Financial Regulatory Authority (FRA). Registered in Egypt (no. 804)..© Thndr. All rights reserved
Hello👋 We want you to be able to express your opinions on anything and everything finance and economics related to the Egyptian and US markets.
This is why we introduced Thndr Thinkers💭
Let’s go through some housekeeping notes before you jump into publishing your article to all Thndr Claps readers!
Type of Content📝 We want to see market-relevant content that shows good analysis, please! Base your articles on facts
Don’t be shy, explain🗣 Flex your knowledge to us, and we’ll share it with all the readers!
Be Original🙏 Please don’t copy. No one likes a copycat. All submissions are welcome as long as they’re yours
Make your title attractive🤩 A title is like the cover of your book. Attractive enough to make you look at the book but also clear enough to tell you what the book is about.
Clean🧹 We’re all humans and we all make mistakes. But please try and clean up the article so it’s clear for all the readers
No promotional content🚫 We don’t publish promotional content.
Any questions about becoming a Thndr Thinker? Email firstname.lastname@example.org and we’d be happy to help!
Normally, your article will be published within 24 hours of submission (if you followed the guidelines)